Recommended Free Tools
Short answer: A variant of uncertain significance (VUS) is a genetic change for which current evidence is not sufficient to tell whether it is associated with disease. It is an evidence category, not a diagnosis. The ACMG/AMP guidance is explicit: “A variant of uncertain significance should not be used in clinical decision making.”
A VUS does not confirm autism, explain a child’s traits, predict prognosis, or by itself justify treatment, medical surveillance, insurance decisions, or reproductive decisions. The useful next step is a genetics-informed review of the complete report, the person’s developmental history and symptoms, and whether laboratory reanalysis or carefully selected family testing could add evidence.
As an Amazon Associate I earn from qualifying purchases.
What a VUS means on the report
Laboratories classify genetic findings according to the evidence available for that particular change. The standard five categories are:
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
| Classification | What it generally indicates | What it can and cannot establish |
|---|---|---|
| Pathogenic | Evidence supports that the variant causes or contributes to a disease or condition. | It may help explain a person’s features when the gene, condition and clinical findings fit. A clinician still has to interpret the result in context. |
| Likely pathogenic | Evidence strongly favors a disease association, but does not meet the laboratory’s threshold for “pathogenic.” | It can be clinically meaningful when the phenotype and gene-disease relationship are consistent, with professional interpretation. |
| Variant of uncertain significance | Available evidence is insufficient, or sometimes conflicting, to determine whether the change is associated with disease. | It is not a diagnosis and should not drive medical or reproductive decisions. |
| Likely benign | Evidence favors the change being harmless, although a small amount of uncertainty remains. | It is generally not used as an explanation for the person’s condition. |
| Benign | Evidence supports that the change does not cause disease. | It is not considered an explanation for disease-related features. |
The classification describes the strength of evidence about the variant. It does not, by itself, describe the person’s diagnosis or the severity of symptoms. A laboratory can update a classification when new population, family-segregation, functional or clinical evidence becomes available.
#1 Best Overall
- [Ultra-Lightweight Ear Buds Designed for Small Ears] Each earbud weighs only 3.7g and features a compact, ergonomic in-ear design made especially for small ears. Secure, low-profile, and comfortable for workouts, all-day wear or overnight sleeping.The ultra-slim profile sits flush in your ear with no hard edges poking or rubbing, so you can even sleep on your side without discomfort.
- [Immersive Stereo Sound with TOZO OrigX Technology] TOZO OrigX tuning delivers clear vocals, balanced mids, and natural stereo sound for music, podcasts, and videos.
- [Long Battery Life for Daily Use] Get up to 7 hours of playtime on a single charge, with up to 32 hours total using the charging case—ideal for workdays, commuting, and extended listening sessions.
- [Bluetooth 5.3 & Stable Connection] Bluetooth 5.3 provides fast pairing, stable wireless performance, and reduced dropouts as you move around home or office.
- [Deep Bass with Clear Vocals] High-performance drivers produce punchy bass while keeping vocals clean and detailed for everyday listening.
The American College of Medical Genetics and Genomics (ACMG) defines a VUS as “a genetic change for which there is currently insufficient evidence to determine whether it is associated with a disease.” “Currently” matters: the category reflects what is known at the time of reporting, not a prediction that the result will eventually become pathogenic.
What a VUS does—and does not—say about autism
Autism spectrum disorder (ASD) is diagnosed clinically. A developmental assessment considers communication, social interaction, restricted or repetitive behaviors, developmental history and functioning across settings. Genetic testing may help identify an etiology or associated medical risks, but the American Academy of Pediatrics (AAP) states that genetic tests are not diagnostic of ASD.
No single mutation is unique to autism. The same gene finding can occur in people with intellectual disability, epilepsy or other neurodevelopmental conditions, and people with autism can have different genetic or non-genetic contributors. The AAP reported that no individual pathogenic variant accounts for more than 1% of ASD cases. A VUS therefore cannot be used to establish that a child has autism, to rule autism out, or to forecast how the child will develop.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteHow often genetic testing finds something in ASD evaluations
Published AAP figures illustrate why a report can contain uncertain findings and why a result must not be read as a simple yes-or-no autism test. These are population-level results from clinical studies, not the probability that a particular child’s VUS is important.
| Test or finding | Figure reported by the AAP (2020) | How to interpret the number |
|---|---|---|
| Chromosomal microarray (CMA), including copy-number variants of uncertain significance | Approximately 17%–42% of children with ASD had a finding. | The range includes uncertain copy-number findings, so it is not a rate of definitive diagnoses. |
| CMA, definitively pathogenic copy-number variants | 5.4%–14%, with a median of 9%, in clinical ASD samples. | These are pathogenic CNVs, not all reported variants and not VUS results. |
| Whole-exome sequencing (WES) | 26%–29% molecular-diagnosis yield in large clinical studies in which neurodevelopmental disorders were the primary indication. | The figure applies to those study populations and indications; it is not an autism-specific guarantee. |
Read the report before drawing conclusions
1. Identify the exact finding
Ask for the complete laboratory report, not only a portal summary. Record the gene name, the exact variant nomenclature, the transcript used, the laboratory’s classification and the test type. A sequence variant and a copy-number variant (CNV) are different kinds of findings and may be described in different formats.
Rank #2
- 【IP68 Waterproof Multifunctinal Smart Watch】Torjalph fitness activity tracker smart watch is IP68 waterproof technology ,you can wear it when swimming,handwashing,it's rain-proof which means that you perform multiple exercise modes outside without worrying about sweat or rain corroding your fitness smart watch,and this watch equipped with a 230 mAh large capacity battery magnetic charging ,and this sports activity tracker watch can be used 5-7 days If fully charged.
- 【Larger 1.83'' Full Screen Watch & Multi-dial Selection】1.83 inch full HD color touch screen smart watch for men / women provides excellent 240*284 resolution image quality ,This Bluetooth smart watch offers a better touch experience and remarkable immersion and ,more than 200 watch faces for you to choose from App"Da Fit ", you can change the dial style according to your mood to wear keeping the world on your wrist
- 【Accurate Activity Tracker Smart Watch 】sports watch activity tracker uses sweat and dust resistant breathable silicone strap, our Fitness Tracker Smart Watch for Android iOS Phones supports 12 sports modes,walking,running,bicycle,swimming,badminton,basketball,football,rope skipping. This bluetooth calls smart watch for men women is lightweight and stylish, bringing more convenient and relaxing sports experience while also providing more protection.
- 【Your 24 Hour Personal Daily Health Monitor】Fitness watch for women men full touch screen IP67 waterproof bluetooth smartwatch for Android iOS Phones with heart rate blood pressure monitor multifunction Andriod smart watch with steps counter sleep monitor sports fitness watch, monitoring blood oxygen saturation allows you to understand your physical condition in real time to track fitness progress ,to know your health status in time.
- 【More Functions Bluetooth Call Smart Watch】This fitness activity smart watch full screen for iPhone and Android phones includes a bunch of new features including:The bluetooth smart watch can hang up the phone, receive and display WhatsAPP /Text /Facebook /Twitter /Messenger reminder.Support sedentary reminder, alarm clock, stopwatch, timer,weather information,music control, remote camera control compatible with Android 5.0 and above or iOS 9.0 and above smartphones.
Small differences in transcript choice or variant notation can refer to different changes. The exact wording is needed if a genetics professional checks other databases, compares laboratories or requests reanalysis.
2. Check what the test was designed to detect
Find out whether the result came from CMA, a targeted panel, WES, whole-genome sequencing or another test. Each method has different coverage and limitations. A negative result, a VUS and a pathogenic result answer different questions; none replaces a clinical developmental evaluation.
3. Read the laboratory’s evidence summary
Look for the reasons the laboratory assigned a VUS. The report may discuss population frequency, computational predictions, laboratory experiments, observations in affected or unaffected relatives, and previously reported patients. It may also list conflicting classifications from other laboratories. Conflicting entries are a reason for professional review, not a reason to choose the most alarming interpretation.
4. Ask whether the gene-disease relationship is established
A variant can be uncertain because the change itself is poorly understood, because the gene’s relationship to a condition is still developing, or because the available evidence points in different directions. Ask whether the gene is firmly established for a condition that matches the person’s features, or whether the gene-disease relationship remains uncertain.
5. Keep the clinical picture separate
Compare the report with the person’s developmental history, examination, learning profile, seizures, growth, congenital findings and other symptoms. Those features help a clinician decide which evaluations are appropriate, but they do not convert a VUS into a diagnosis.
Rank #3
- [Low Noise High Fidelity] New bee guitar cord with 22AWG oxygen-free-copper center conductors provides enhanced signal transfer, the PVC insulation material and the high-density stranded copper double shield provide noise rejection for quiet operation
- [Ideal for Choice] New bee 1/4 straight and right angle metal connectors, ensures a secure connection in any instrument, pedal, or amp jack. L shape great fro on stage guitar stands
- [Wide Compatible] Suitable for mixer, power amplifier, microphone, effector, decoder, equalizer, electoronic organ, electric guitar, electric bass and other electronic equipments. Widely used in the installation of smart home, karaoke speaker, professional stage audio, etc
- [Easy Disassemble] Making incidental repairs quick and easy! Very nice, flexible cable
- [Dont Hesite to Order] 24 hours customer services and professional technology team are standing by
What to do after receiving a VUS
- Save the full report and the date. Keep the original PDF, the laboratory’s contact information and any later amended versions. Portal summaries can omit the evidence discussion and test limitations.
- Discuss it with the ordering clinician or a genetics professional. The AAP recommends offering genetic evaluation for children with ASD and describes referral to genetics, CMA, fragile-X testing and possible WES depending on the history and prior results. A genetic counselor can explain why the test was ordered and what this specific report does and does not establish.
- Continue care based on symptoms and developmental assessment. Speech-language, educational, behavioral, occupational, seizure and other medical services should be guided by documented needs and established diagnoses, not by the VUS.
- Ask whether additional testing would answer a defined question. The clinician may consider a different test, a test for a parent or another relative, or no additional testing if it is unlikely to change interpretation. More testing is not automatically better.
- Ask the laboratory about reanalysis and amended reports. Find out whether the laboratory reanalyzes variants on request, whether it has a suggested review process, and how it communicates an amended classification. Do not assume that the laboratory will automatically locate every patient or that every VUS will be revisited on a fixed schedule.
- Document who is responsible for follow-up. Record whether the ordering clinic, genetics service or laboratory will be contacted if new information appears. This avoids losing track of a result when clinicians or contact details change.
Can the classification change?
Yes. A VUS can later be classified as benign, likely benign, likely pathogenic or pathogenic, or it can remain uncertain. New evidence may come from larger population databases, studies of how the gene or protein functions, observations in additional patients, or segregation testing in relatives. Reclassification is possible, not promised.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →There is no published universal timetable that applies to every VUS. Laboratories differ in whether they perform routine reanalysis, how often they accept a reanalysis request and how they contact patients. Ask those questions directly and keep your own copy of the report so that a future clinician can request review if appropriate.
| Possible later outcome | What it means for the next conversation |
|---|---|
| Benign or likely benign | The variant becomes less likely to be relevant to the person’s condition. Clinical care still follows the person’s symptoms and diagnoses. |
| Pathogenic or likely pathogenic | A genetics professional assesses whether the gene, condition and clinical findings fit and whether the result has implications for medical evaluation or family recurrence risk. |
| Still a VUS | No new clinical conclusion can be drawn from that finding. The laboratory’s updated evidence may nevertheless explain why uncertainty remains. |
| Conflicting laboratory classifications | Ask a genetics professional or the laboratory to explain the evidence behind each classification. Do not select one based only on its position in a report or on an internet search. |
Should parents or other relatives be tested?
Family testing is case-specific. Testing a parent or another relative can provide segregation evidence—information about how the variant tracks with features in a family—but it can also be uninformative, technically difficult to interpret or emotionally confusing. A genetics professional should decide whether the particular variant and family structure make testing worthwhile.
| Question | Potential value | Limitations |
|---|---|---|
| What is the purpose? | To add evidence about inheritance or segregation and, in selected cases, clarify recurrence-risk counseling. | A result may not change the VUS classification, and absence or presence in a relative may not be decisive. |
| Who should order it? | The ordering clinician or genetics professional can choose the appropriate relatives and test method. | Direct-to-consumer or unsupervised testing may not use the same methods or interpretation standards as the clinical laboratory. |
| What could it clarify? | It may help connect the variant with, or separate it from, patterns of features in the family. | Relatives can have different symptoms, age-related features or unrelated conditions, making the pattern difficult to interpret. |
| What about cost and access? | Some laboratories offer family studies under defined policies. | Coverage, eligibility, laboratory policy and access to local genetics services vary. Confirm costs before testing. |
Do not test relatives simply because a report contains a VUS. First ask what decision the result would inform and whether the laboratory has a validated family-testing pathway for that finding.
Can a VUS be treated?
There is no treatment for a VUS itself. A VUS should not be used to prescribe supplements, medication, diets, procedures or other unproven interventions. It also should not, by itself, trigger surveillance for a syndrome, change educational placement, or determine whether a person receives autism-related services.
Rank #4
- Digital Family Calendar: BSIMB digital calendar wall touch screen puts an end to your chaotic life. Designed for busy families, the digital calendar keeps you organised and in step with your family. Assign different colours and tasks to each family member to make family scheduling easier and more intuitive.
- Easy Setup and Auto-Sync: Plug in, connect to WLAN and auto-syn your electric calendar in minutes. Digital wall calendar compatible with Google calendar, iCloud calendar, Outlook calendar, Cozi calendar and Yahoo calendar. Add events directly on the device or through the ecalendar app. Electronic calendar stays current whether you're at work or traveling—no manual updates needed.
- All-In-One Home Assistant: Smart calendar builds habits and encourage independence with personalised chores. Display daily meal plan to reduce the daily ‘What's for dinner?’ stress. To-do lists keep track of everything you want. Turning chores into valuable achievements with stars and rewards, making life easier and more enjoyable.
- Manage Anytime Anywhere: BSIMB electronic calendar for family stay connected with the powerful ecalendar app. Access and manage your digital wall calendar anytime, anywhere with free features like stars & rewards, photo screensaver, chore charts, meals plans, to-do lists etc. Electronic planner paid features like Magic Import tailor advanced tools for users with special needs.
- Stay in Touch with Loved Ones: Share photos or videos from your phone to electronic wall calendar with app, instantly update your life moment, and keep in touch with your family, especially those who are far away; you can also surprise your smart calendar digital wall by sending him a wish card; it's also great for keeping tech-illiterate elders in touch with the youngsters.
Care should continue according to the person’s symptoms, developmental assessment and established clinical diagnoses. If a clinician identifies a separate medical concern—such as seizures, hearing loss, sleep problems or developmental regression—that concern deserves evaluation regardless of the VUS.
Likewise, do not make reproductive decisions or insurance decisions from a VUS alone. If a family is considering pregnancy or needs help understanding recurrence risk, a genetics professional can explain what is and is not known and identify which findings, if any, are clinically established.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Choosing the right follow-up option
Several follow-up paths may be discussed. They answer different questions and should not be treated as interchangeable.
| Option | Purpose | Who usually initiates it | Potential benefit | Main limitations | Cost and access |
|---|---|---|---|---|---|
| Genetic counseling or clinical genetics visit | Explain the report in the context of the person’s history and decide whether further evaluation is appropriate. | Ordering clinician, pediatrician, specialist or genetics service. | Clarifies the diagnosis, test limitations and possible medical or family implications. | Availability may be limited, and the visit cannot resolve evidence that does not yet exist. | Coverage and local availability vary. |
| Laboratory reanalysis | Review the variant using newer evidence or updated classification criteria. | The laboratory, sometimes after a request from the ordering clinician. | May move a VUS toward benign or pathogenic, or explain why it remains uncertain. | No universal timetable; some laboratories do not automatically recontact patients. | Policies, fees and eligibility differ by laboratory. |
| Targeted testing of parents or relatives | Generate segregation evidence for the specific variant. | A genetics professional in coordination with the laboratory. | Can add family evidence when the variant and family structure are suitable. | May be uninformative or create additional uncertainty; it is not appropriate for every VUS. | Coverage, family availability and laboratory policy vary. |
| Additional clinical testing | Investigate symptoms or developmental concerns independent of the VUS. | The clinician who evaluates the relevant symptom. | Can identify treatable or supportable conditions without relying on an uncertain genetic finding. | Testing should be driven by clinical indications, not by the desire to force a VUS into an answer. | Requirements and coverage depend on the test and health system. |
Questions to take to the appointment
- What is the exact variant nomenclature, gene, transcript and test type—sequence variant or CNV?
- Which evidence led the laboratory to call it a VUS?
- Does the report identify conflicting classifications from other laboratories?
- Is the gene established for a condition relevant to this person’s features, or is the gene-disease relationship still uncertain?
- Would testing either parent or another relative add useful segregation evidence?
- Who would order family testing, and what would each possible result change?
- How does this laboratory perform reanalysis?
- How often should the report be reviewed, given that there is no universal reclassification interval?
- How will an amended report be communicated, and who is responsible for keeping contact details current?
- Are there clinical evaluations indicated by the person’s symptoms regardless of the VUS?
- Which current services or treatments should continue based on the developmental assessment?
Common interpretation mistakes
“Uncertain” means “probably harmful”
It does not. Uncertain means the available evidence does not support a reliable disease association in either direction. Treating the label as a warning sign overstates what the laboratory knows.
The VUS proves the child has autism
It does not. Autism requires clinical assessment, and genetic findings can overlap with several neurodevelopmental conditions. The VUS cannot substitute for that assessment.
Best Value
A website or database search can settle the result
Public entries can be outdated, incomplete or based on different evidence. An individual report must be interpreted with its exact transcript, laboratory methods, phenotype and family information. Use the ordering laboratory and qualified genetics professionals for individualized interpretation.
More family testing is always better
Family testing is useful only when it addresses a defined question and the result can be interpreted. Testing without a plan can add findings without adding clarity.
The laboratory will definitely call later
Recontact practices differ. Ask how amended reports are handled, keep the report and date, and arrange a review process through the ordering clinician or genetics service.
A VUS should change treatment now
ACMG/AMP guidance rules out using a VUS for clinical decision making. Continue evidence-based care for the person’s actual symptoms and diagnoses while the genetic finding remains unresolved.
How to explain the result to family members
A precise explanation is often simpler than a dramatic one: “The test found a genetic change, but the laboratory does not yet know whether it affects health. It does not diagnose autism or tell us what treatment to use. We are asking a genetics professional whether the report should be reanalyzed or whether family testing would add useful evidence.” This wording preserves what is known without turning uncertainty into a prediction.
Bring the full report to the next appointment, along with developmental evaluations and a list of current symptoms. That information allows the clinician to address the person’s needs now while keeping the unresolved genetic finding in its proper place.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →

